½ÃÀ庸°í¼­
»óǰÄÚµå
1654182

¼¼°èÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, °ø±Þ¿øº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)

Astaxanthin Market Size, Share & Trends Analysis Report By Product (Oil, Softgel, Liquid), By Source (Natural, Synthetic), By Application (Aquaculture & Animal Feed, Nutraceuticals), By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå ±Ô¸ð´Â 2025-2030³â µ¿¾È 14.74%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇϸç, 2030³â±îÁö 38¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¿µ¾çº¸Á¶½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í µ¿¹°»ç·á»ê¾÷°ú ¾ç½Ä¾÷¿¡ À־ Ä«·ÎƼ³ëÀ̵åÀÇ ¿ëµµ È®´ë°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, ±Þ¼ÓÇÑ ³ëÈ­¿Í ¼ÒºñÀÚ °Ç°­ ÀÇ½Ä Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÏ´Â °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ¼ö»ê ¾ç½Ä°ú ¾î¾÷ ºÎ¹®ÀÇ ¼ºÀåÀ¸·Î ¼ºÀå ±âȸ¸¦ ¸ñ°ÝÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î µ¶ÀÏ¿¡¼­´Â ¹°°í±â »ý»ê·®ÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç µ¶ÀÏ ¿¬¹æ Åë°è±¹¿¡ µû¸£¸é 2021³â¿¡´Â ¾à 1¸¸ 8,300ÅæÀÇ ¹°°í±â°¡ »ý»êµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿°·á´Â µ¿¹°ÀÇ ¸é¿ª·ÂÀ» ³ôÀÌ°í °ü»ó¿ë ¹°°í±â¿Í ¹«Áö°³¼Û¾î¿Í °°Àº ¼ö»ý µ¿¹°ÀÇ ¿°·á¸¦ °­È­ÇÏ´Â µ¥ µµ¿òÀ̵DZ⠶§¹®¿¡ Àü ¼¼°èÀÇ ¾ç½Ä ºÐ¾ßÀÇ ¼ºÀåÀº ¾Æ½ºÅ¸Å© »êƾ ¼ö¿ä¸¦ ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¶ÇÇÑ, ½ÃÀåÀÇ ¼ºÀåÀº ¾Æ½ºÅ¸ÀÜÆ¾ÀÇ Ã¤¿ëÀ» Áõ°¡½Ã۱â À§ÇØ ´Ù¾çÇÑ R&D Ȱµ¿¿¡ ÀÇÇØ ºÎÃß°ÜÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 12¿ù, AstaReal°ú ¾²Äí¹Ù´ëÇÐÀº ¾Æ½ºÅ¸ÀÜÆ¾ ºÐÀÚ°¡ ´º·± Çü¼º, ±â¾ï, ÇнÀ¿¡ °ü¿©ÇÏ´Â ³úÀÇ À¯ÀüÀÚ¸¦ Á¶ÀýÇÑ´Ù´Â »õ·Î¿î ƯÇã¿Í ¿¬±¸¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ 2020³â 7¿ù¿¡´Â SPbPU¿Í TUHHÀÇ ·¯½Ã¾Æ¿Í µ¶ÀÏ ´ëÇÐ °úÇÐÀÚµéÀÌ Ç×»êÈ­ ¿ëµµÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ »ý»êÀ» °­È­Çϱâ À§ÇÑ °øµ¿ ¿¬±¸¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

¶ÇÇÑ, õ¿¬ ¾Æ½ºÅ¸ÀÜÆ¾ÀÇ °Ç°­»óÀÇ ÀÌÁ¡°ú °ü·ÃµÈ ¿¬±¸ Áõ°¡´Â ½ÃÀå ¼·Ã븦 Áõ°¡½Ãų °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù, American Journal of Clinical Nutrition¿¡ ÀÇÇØ ¹ßÇ¥µÈ ¿¬±¸¿¡¼­ Å©¸± ¿ÀÀÏÀº 40¼¼¿¡¼­ 65¼¼ »çÀÌÀÇ °ñ°üÀý¿° ¹× ¹«¸­ ÅëÁõÀÌ ÀÖ´Â ¼ºÀÎÀÇ °æÁ÷, ¹«¸­ ÅëÁõ, ½Åü ±â´É °ü¸®¿¡ µµ¿òÀÌ µÉ °ÍÀ̶ó°í ¸»Çß½À´Ï´Ù.

¶ÇÇÑ ±¹Á¦ ½ÃÀå¿¡¼­ ¾Æ½ºÅ¸ÀÜÆ¾ÀÇ ³ôÀº ¼ö¿ä·Î ÀÎÇØ ´Ù¾çÇÑ ¼±µµ ±â¾÷µéÀº ÀÚ»ç Á¦Ç°À» ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï °ø±Þ¸Á ´É·ÂÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù, Atacama Bio Natural Products SA´Â Áß±¹¿¡¼­ ÆÇ¸Å¸ÁÀ» ÃËÁøÇϱâ À§ÇØ Guangzhou Carelife Food Additives Co, Ltd.¿Í µ¶Á¡ ÆÇ¸Å °è¾àÀ» ü°áÇß½À´Ï´Ù. °Ô´Ù°¡ 2022³â 6¿ù, Pharmactive Biotech Products´Â ½Ì°¡Æ÷¸£ÀÇ Nutraconnect¿Í Á¦ÈÞÇØ °úÇÐÀû µÞ¹ÞħÀÌ ÀÖ´Â ½Å±Ô ¿µ¾ç º¸Á¶ ½ÄǰÀ» ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå¿¡ µµÀÔÇÕ´Ï´Ù.

°Ô´Ù°¡ Áö¿ø ±ÔÁ¦ Á¤Ã¥°ú Á¦Ç° ½ÂÀÎ Áõ°¡´Â »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù, NextFern Technologies´Â ij³ª´Ù º¸°ÇºÎ·ÎºÎÅÍ AstafernÀÇ ±ÔÁ¦ Àΰ¡¸¦ ¹Þ¾Ò½À´Ï´Ù. Astafern´Â ±¸¹Ì ¸ð¾çÀÇ Çõ½ÅÀûÀÎ ¹ßÈ¿ ¾Æ½ºÅ¸ÀÜÆ¾ Ç×»êÈ­ ¹°ÁúÀÔ´Ï´Ù. ¶ÇÇÑ Á¤ºÎ´Â Ä«·ÎƼ³ëÀÌµå ±â¹Ý Âø»ö·á¿Í Ä«·ÎƼ³ëÀÌµå ±â¹Ý Âø»ö·á¸¦ Æ÷ÇÔÇÑ È¥ÇÕ »ç·á¿¡ ´ëÇÑ µî·Ï ¿ä°ÇÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • õ¿¬ ºÎ¹®Àº 2024³â 58.45%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ³ôÀº È¿´É°ú Áö¼Ó°¡´É¼º µîÀÇ ÀÌÁ¡À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • °ÇÁ¶ Á¶·ù ºÐ¸» ¶Ç´Â ¹ÙÀÌ¿À¸Å½º´Â ³ôÀº ¼öÀ²°ú ºñ¿ë È¿°ú·Î 2024³â¿¡ 25.12%ÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¼ö»ê ¾ç½Ä ¹× µ¿¹°»ç·á ºÎ¹®Àº »ç·á ÷°¡Á¦·Î¼­ÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î 2024³â¿¡ 46.07%ÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. õ¿¬ º¯Á¾Àº ¼ÒºñÀÚÀÇ ¼±È£¸¦ À¯µµÇÏ´Â Áß¿äÇÑ ¿ä¼Ò ÀÎ ¿¬¾î, ¼Û¾î, »õ¿ìÀÇ ºÓÀº »ö¼Ò Ä§ÂøÀ» À¯µµÇÏ´Â »ç·á·Î »ç¿ëµË´Ï´Ù.
  • ºÏ¹ÌÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀåÀº 2024³â 35.27%ÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í °Ç°­ º¸ÃæÁ¦ ¹× È­ÀåǰÀ¸·Î õ¿¬ Ç×»êÈ­Á¦ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅëÀÇ Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå ºÐ¼® µµ±¸
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
  • ű¹ÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ¼öÀÔ·® µ¥ÀÌÅÍ

Á¦4Àå ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : °ø±Þ¿øº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • °ø±Þ¿ø ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : °ø±Þ¿øº° Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
    • õ¿¬
    • ÇÕ¼º

Á¦5Àå ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : Á¦Ç°º° Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
    • °ÇÁ¶ Á¶·ù ºÐ¸» ¶Ç´Â ¹ÙÀÌ¿À¸Å½º
    • ±â¸§
    • ¼ÒÇÁÆ®Á©
    • ¾×ü
    • ±âŸ

Á¦6Àå ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : ¿ëµµº° Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
    • ¿µ¾çº¸Á¶½Äǰ
    • È­Àåǰ
    • ¼ö»ê ¾ç½Ä ¹× µ¿¹°»ç·á
    • ½Äǰ

Á¦7Àå ¾Æ½ºÅ¸ÀÜÆ¾ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°è Áö¿ª ½ÃÀå ÇöȲ
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀïÀÇ ºÐ·ù
  • º¥´õ »óȲ
    • ÁÖ¿ä ¸®¼¿·¯¿Í ä³Î ÆÄÆ®³Ê ¸ñ·Ï
    • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
    • Algatech Ltd
    • Cyanotech Corporation
    • Algalif Iceland ehf
    • Beijing Gingko Group(BGG)
    • PIVEG, Inc.
    • Fuji Chemical Industries Co., Ltd
    • ENEOS Corporation
    • Atacama Bio Natural Products SA
    • EID-Parry(India) Limited
    • ALGAMO
JHS 25.03.10

Astaxanthin Market Growth & Trends:

The global astaxanthin market size is expected to reach USD 3.89 billion by 2030, registering a CAGR of 14.74% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for nutraceuticals and growing applications of carotenoids in the animal feed industry & aquaculture are the major factors driving the market growth. Moreover, the rapidly aging population and the growing health awareness among consumers are likely to support market expansion.

The market is anticipated to witness growth opportunities owing to growth in the aquaculture and fishing sectors. For instance, Germany is expanding its fish production and according to the federal statistical office of Germany, the country produced around 18,300 tons of fish in 2021. The growth in the aquaculture sector across the globe is likely to propel the demand for astaxanthin as the pigment helps to boost the immunity of animals and enhance the pigmentation of aquatic animals, such as ornamental fish, and rainbow trout.

Moreover, the market growth is also fueled by various research & development activities to increase the adoption of astaxanthin. For instance, in December 2021, AstaReal and the University of Tsukuba announced a new patent and research showing that the astaxanthin molecules modulate the genes of the brain involved in neuron formation, memory, and learning. Moreover, in July 2020, Russian and German university scientists from SPbPU and TUHH announced a collaboration to enhance the production of astaxanthin for its antioxidant application.

Moreover, increasing studies related to the health benefits of natural astaxanthin are expected to increase the market uptake. For instance, in August 2022, a study published by the American Journal of Clinical Nutrition stated that krill oil can help manage stiffness, knee pain, and physical function in adults with osteoarthritis & knee pain between the ages of 40 and 65 years.

In addition, owing to the high demand for astaxanthin in international markets various leading players are strengthening their supply chain capabilities to make their products available. For instance, in July 2021, Atacama Bio Natural Products S.A. signed an exclusive distribution agreement with Guangzhou Carelife Food Additives Co., Ltd. to promote its distribution network in China. Moreover, in June 2022, Pharmactive Biotech Products partnership with Singapore-based Nutraconnect to introduce scientifically backed novel nutraceuticals into the Asia Pacific market.

Furthermore, supportive regulatory policies and increasing approval of products are driving the industry's growth. For instance, in July 2021, NextFern Technologies received regulatory approval for its Astafern from Health Canada. Astafern is an innovative fermented astaxanthin antioxidant in form of gummies. In addition, the government has undertaken supportive registration requirements for carotenoid-based coloring agents and mixed feeds containing carotenoid-based coloring agents.

Astaxanthin Market Report Highlights:

  • The natural segment held the largest revenue share of 58.45% in 2024 and is anticipated to grow at the fastest CAGR during the forecast period, owing to advantages such as high efficacy and sustainability.
  • Dried algae meal or biomass accounted for the largest share of 25.12% in 2024 due to its high yield and cost-effectiveness.
  • The aquaculture & animal feed segment held the largest share of 46.07% in 2024, owing to its extensive use as a feed additive. Natural variants are used as feed to induce reddish pigmentation in salmon, trout, and shrimp, which is an important factor driving consumer preference.
  • North America astaxanthin market accounted for the largest share of 35.27% in 2024 due to its advanced healthcare infrastructure and growing demand for natural antioxidants in health supplements and cosmetics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Product
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Source outlook
    • 2.2.2. Product outlook
    • 2.2.3. Application
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Astaxanthin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for nutraceuticals and natural antioxidants
      • 3.2.1.2. Introduction of advanced technologies
      • 3.2.1.3. Increase in adoption of natural cosmetics, nutraceuticals and pharmaceuticals
      • 3.2.1.4. Increased use in aquaculture and coloring of fish
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of production
      • 3.2.2.2. Excess space requirement
  • 3.3. Astaxanthin Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Import Volume Data for Astaxanthin in Thailand (Volume in Metric Tons)

Chapter 4. Astaxanthin Market: Source Estimates & Trend Analysis

  • 4.1. Source Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Astaxanthin Market by Source Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Natural
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Yeast
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Krill/Shrimp
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Microalgae
        • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Others
        • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Synthetic
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Astaxanthin Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Astaxanthin Market by Product Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Dried algae meal or Biomass
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Oil
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Softgel
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Liquid
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Astaxanthin Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Astaxanthin Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Nutraceuticals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Cosmetics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Aquaculture and Animal Feed
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Food
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.4.2. Functional Food and Beverages
        • 6.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.4.3. Other traditional food manufacturing applications
        • 6.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Astaxanthin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Algatech Ltd
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Cyanotech Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Algalif Iceland ehf
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Beijing Gingko Group (BGG)
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. PIVEG, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Fuji Chemical Industries Co., Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. ENEOS Corporation
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Atacama Bio Natural Products S.A.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. E.I.D. - Parry (India) Limited
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. ALGAMO
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦